Microbiological risk assessment in stem cell manipulation

Critical Reviews in Microbiology

Volumn 34, Issue 1, 2008, Pages 1-12

  Pessina, Augusto ^a   Bonomi, Arianna ^a   Baglio, Carolina ^a   Cavicchini, Loredana ^a   Sisto, Francesca ^a   Neri, Maria Grazia ^a   Gribaldo, Laura ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b JOINT RESEARCH CENTRE   (Italy)

Author keywords

Microbiological Risk; Safety; Stem Cell

Indexed keywords

ARTICLE; CELL CULTURE; CELL ISOLATION; CELL MANIPULATION; CELL SEPARATION; CELL THERAPY; CLINICAL RESEARCH; CONTAMINATION; CRYOPRESERVATION; DISEASE TRANSMISSION; EVOLUTION; HUMAN; INFECTION PREVENTION; MICROBIAL CONTAMINATION; MICROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; STEM CELL;

DISEASE TRANSMISSION; HUMANS; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 38949202264     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.1080/10408410701683599     Document Type: Article

References (27)

1. Barrett, B.B., Andersen, J.W., and Anderson, K.C. 1993. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 33, 228-233.
2. Bielanski, A., Bergeron, H., Lau, P.C., and Devenish, J. 2003. Microbial contamination of embryos and semen during long banking in liquid nitrogen. Cryobiology 46, 146-152.
3. Cobo, F., Stacey, G.N., Cortés, J.L., and Concha, A. 2006. Environmental monitoring in stem cell banks. Appl. Microbiol. Biotech. 70, 651-662.
4. Cobo, F., Stacey, G.N., Hunt, C., Cabrera, C., Nieto, A., Montes, R., Cortes, J.L., Catalina, P., Barnie, A., and Concha, A. 2005. Microbiological control in stem cell banks: approaches to standardisation. Appl. Microbiol. Biotech. 68, 456-466.
5. European Pharmacopoeia: http://online.pheur.org
6. Fountain, D., Ralston, M., Higgins, N., Gorlin, J.B., Uhl, L., Wheeler, C., Antin, J.H., Churchill, W.H., and Benjamin, R.J. 1997. Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion 37, 585-591.
7. Hoher, P.G. 1996. Microbial safety of blood products. Infusionsther. Transfusionsmed. 23, 42-58.
8. Jacobson, S. 2006. The emerging role of HHV-6 in neurologic disease: lesson from multiple sclerosis and epilepsy. Retrovirology 3, S64.
9. Khaiboullina, S.F., Maciejewski, J.P., Crapnellm K., Spallone, P.A., Dean Stock, A., Pari, G.S., Zanjani, E.D., and Jeor, S.S. 2004. Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Brit. J. Hematol. 126, 410-417.
10. Khuu, H.M., Cowley, H., David-Ocampo, V., Carter, C.S., Kasten-Sportes, C., Wayne, A.S., Solomon, S.R., Bishop, M.R., Childs, R.M., and Read, E.J. 2002. Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences. Cytotherapy 4, 539-549.
11. Martinez, O.V., Buck, B.E., Hernandez, M., and Malinin, T. 2003. Blood and marrow cultures as indicators of bone contamination cadaver donors. Clin. Orthop. 409, 317-324.
12. Meijer, E., Spijkers, S., Moschatsis, S., Boland, G.J., Thijsen, S.F.T., van Loon, A.M., and Verdonck, L.F. 2005. Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation? Transpl. Infect. Dis. 7, 4-10.
13. Morel, P., Roubi, N., Bertrand, X., Lapierre, V., Tiberghien, P., Talon, D., Hervé, P., and Delbosc, B. 2003. Bacterial contamination of a cornea tissue bank: implications safety of graft engineering. Cornea 22, 221-225.
14. Morgan, D., and Brodsky, I. 2004. Human endogenous retoviruses (HERV-K) particles in megakaryocytes cultured from essential thrombocythemia peripheral blood stem cells. Exp. Hematol. 32, 520-525.
15. Noda, S., Aguirre, S.A., Bitmansour, A., Brown, J.M., Sparer, T.E., Huang, J., and Mocarski, E.S. 2006. Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood. 107, 30-8.
16. Padley, D.J., Greiner, C.W., Heddlesten, T.L., Hopkins, M.K., Maas, M.L., and Gastineau, D.A. 2003. Endogenous microbial contamination of cultured autologous preparation in trials of cancer immunotherapy. Cytotherapy 5, 147-152.
17. Pi, W., Yang, Z., Wang, J., Ruan, L., Yu, X., Ling, J., Krantz, S., Isales, C., Conway, S.J., Lin, S., and Tuan, D. 2004. The LTR enhancer of ERV-9 human endogenous retrovirus is active in oocytes and progenitor cells in transgenic zebrafish and humans. PNAS 101, 805-810.
18. Smirnov, S.V., Harbacheuski, R., Lewis-Antes, A., Zhu, H., Rameshawar, P., Kotenko, S.V. 2007. Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential. Virology 360, 6-16.
19. Sotgiu, S., Arru, G., Mameli, G., Serra, C., Pugliatti, M., Rosati, G., and Dolei, A. 2006. Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a Sardinian cohort. Multiple Sclerosis 12, 698-703.
20. Sugai, Y., Sugai, K., and Fuse, A. 2001. Current status of bacterial contamination of autologous blood transfusion. Transfus. Apheresis. Sci 24, 255-259.
21. Sundin, M., Örvell, C., Rasmusson, I., Sundberg, B., Ringden, O., and Le Blanc, K. 2006. Mesenchymal stem cells are susceptible to human herpes viruses, but viral DNA cannot be detected in the healthy seropositive individual. Bone Marrow Transplant. 37, 1051-1059.
22. Urisman, A., Molinaro, R.J., Fischer, N., Plummer, S.J., Casey, G., Klein, E.A., Malathi, K., Magi-Galluzzi, C., Tubbs, R.R., Ganem, D., Silverman, R.H., and DeRisi, J.L. 2006. Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2, 211-225.
23. Urnovitz, H.B., and Murphy, W.H. 1996. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin. Microbiol. Rev. 9, 72-99.
24. U.S. Food and Drug Administration (FDA): http://www.fda.gov
25. Weiss, R.A. 2006. The discovery of endogenous retroviruses. Retrovirology 3, 67.
26. Weis, S., Lienos, I.C., Sabunciyan, S., Dulay, J.R., Isler, L., Yolken, R., and Perron, H. 2007. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. J. Neural. Transm. 114, 645-655.
27. Yamane, A., Mori, T., Suzuki, S., Mihara, A., Yamazaki, R., Aisa, Y., Nakazato, T., Shimizu, T., Ikeda, Y., and Okamoto, S. 2007. Risk factors for developing human herpes virus 6 (HHV-6) reactivation after allogenic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol. Blood. Marrow. Transplant. 13, 100-106.